ليست عنوان مقالات لاتين Hemoptysis and Hematuria as the Initial Symptoms of COVID-19: a Case Report Hepatitis C infection is characterized by a high incidence of liver cirrhosis, frequently requiring liver transplantation. After orthotopic liver transplantation, recurrence of hepatitis C virus infection is common, but often difficult to differentiate fr

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Hemoptysis and Hematuria as the Initial Symptoms of COVID-19: a Case Report

2

Hemoptysis and Massive Hemothorax as Presentation of Intralobar Sequestration

3

Hemoptysis and Upper Gastrointestinal Bleeding In Two Patients Presenting With Aluminum Phosphate Intoxication (Oral and Inhaled): A Case Study

4

Hemoptysis as a Complication of Capitonnage for Management of Pulmonary Hydatid Cyst

5

Hemoptysis as a Rare Presentation of Thoracic Aorta Aneurysm

6

Hemoptysis as an unusual manifestation of right atrial myxoma

7

Hemoptysis caused by aortobronchial fistula

8

Hemoptysis caused by Hughes-Stovin syndrome

9

Hemoptysis demonstrated on Tc99m-sulfur colloid scanning: A rare complication of amoebic liver abscess

10

Hemoptysis from an unusual pulmonary arteriovenous malformation

11

Hemoptysis From Collateral Arteries 12 Years After a Fontan-Type Operation

12

Hemoptysis resulting from unilateral pulmonary artery agenesis

13

Hemoptysis Secondary to Pulmonary Artery Pseudoaneurysm After Necrotizing Pneumonia

14

Hemoptysis secondary to pulmonary pseudoaneurysm 30 years after a gunshot wound

15

Hemoptysis. A rare presentation of a vallecular cyst

16

Hemopump 31, the sternotomy hemopump: Clinical experience

17

Hemopump treatment in patients with postcardiotomy heart failure

18

Hemorheolocical and photoplethysmographical modifications with aging

19

Hemorheological and cardiovascular effects of exercise training in the rehabilitation of elderly patients with chronic obstructive pulmonary disease

20

Hemorheological changes and overproduction of cytokines from immune cells in mild to moderate dementia of the Alzheimer’s type: adverse effects on cerebromicrovascular system.

21

Hemorheological changes with strontium ranelate treatment do not seem to be related to its claimed prothrombotic effects

22

Hemorheology by Microchannel Method in Males with Metabolic Syndrome

23

Hemorrhage activates catecholaminergic neurons sensitive to GABA in the nucleus of the solitary tract with ascending projections to the subfornical organ in rats

24

Hemorrhage Activates Myocardial NFκB and Increases TNF-α in the Heart

25

Hemorrhage after pancreaticoduodenectomy: when is surgery still indicated?

26

Hemorrhage and the Use of Blood Products After Adult Cardiac Operations: Myths and Realities

27

Hemorrhage of the optic dik in normal-tenion glaucoma

28

Hemorrhage Treatment Report of Patients Suffering from Glanzmann’s Thrombasthenia Resulting Hospitalization from 2006 to 2011 at Mofid Children’s Hospital

29

Hemorrhages Seen on Brain Images After Mild Traumatic Brain Injury May Increase the Risk of Post-concussion Syndrome

30

Hemorrhagic and thrombotic disorders due to factor V deficiencies and abnormalities: an updated classification

31

Hemorrhagic ascites: an unusual manifestation of prostate carcinoma

32

Hemorrhagic Auricular Schwannoma: A case report

33

Hemorrhagic bowel syndrome in dairy cattle in Iran: a case report

34

Hemorrhagic brain metastases as a manifestation of metastatic malignant melanoma

35

Hemorrhagic cardiac tamponade in critically ill patients with acute renal failure

36

Hemorrhagic cerebral metastases from thyroid cancer on T2*-weighted gradient echo MRI

37

Hemorrhagic Complication from Glaucoma urgery in Patient on Anticoagulation Therapy or Antiplatelet Therapy Original Reearch Article

38

Hemorrhagic complication in an unupected macular choroidal melanoma

39

Hemorrhagic complications after nephron-sparing surgery: Angiographic diagnosis and management by transcatheter embolization: Heye S, Maleux G, Van Poppel H, Oyen R, Wilms G, Department of Radiology, University Hospitals Gasthuisberg, Belgium

40

Hemorrhagic Complications of Intravenous Heparin Use

41

Hemorrhagic Corpus Luteum is Associated with Ovarian Edema

42

Hemorrhagic Corpus Luteum With Generalized Abdominal Pain in Patients With Idiopathic Thrombocytopenic Purpura

43

Hemorrhagic Cystitis Following Cephalexin Overdose in a Child

44

HEMORRHAGIC DISEASE OF THE NEWBORN: CLINICAL PRESENTATION AND RESPONSE TO TREATMENT WITH VITAMIN K

45

Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis

46

Hemorrhagic enteritis virus induced changes in the lymphocyte subpopulations in turkeys and the effect of experimental immunodeficiency on viral pathogenesis

47

Hemorrhagic Events During Therapy With Recombinant Tissue Plasminogen Activator, Heparin, and Aspirin for Unstable Angina (Thrombolysis In Myocardial Ischemia, Phase IIIB Trial)

48

Hemorrhagic Events in Patients Receiving Heparin or Enoxaparin in Combination With Oral Antithrombotics, NSAIDs, and Antiplatelet Medications: A Multi-Center Case-Series Study

49

Hemorrhagic Fever with Acute Renal Failure: A Report from Kosova

50

Hemorrhagic Fever With Renal Syndrome and Its History in Iran

51

Hemorrhagic Gastritis Associated with Renal Failure, Hemoglobinuria, and Isolation of Clostridium perfringens in a Horse

52

Hemorrhagic pericardial effusion leading to cardiac tamponade, as presenting feature of COVID-19 in a young man: a case report

53

Hemorrhagic Posterior Reversible Encephalopathy Syndrome: A Rare Neurological Complication of COVID-19 Infection

54

Hemorrhagic shock from a ruptured ectopic pregnancy in a patient with a negative urine pregnancy test result

55

Hemorrhagic type Moyamoya disease

56

Hemostasis and exercise

57

Hemostasis as an optimal system

58

Hemostasis by means of a cautery knife equipped with an air spray for burns over a large area

59

Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders

60

Hemostasis in newborns of smoking and nonsmoking mothers, ,

61

Hemostasis in Off-Pump Compared to On-Pump Coronary Artery Bypass Grafting: A Prospective, Randomized Study

62

Hemostasis in Oral Surgery

63

Hemostasis in Overt and Subclinical Hyperthyroidism

64

Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies, , , ,

65

Hemostasis in uncontrolled esophageal variceal bleeding by self−expanding metal stents: a systematic review

66

Hemostasis Management in Pediatric Mechanical Circulatory Support

67

Hemostasis of the femoral vasculature: Shouldn’t we have an answer by now?, ,

68

Hemostasis of Tiger Prawn Penaeus monodon Affected by Vibrio harveyi, Extracellular Products, and a Toxic Cysteine Protease

69

Hemostasis success rates and local complications with collagen after femoral access for cardiac catheterization: Analysis of 6007 published patients, ,

70

Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge

71

Hemostatic Agents

72

Hemostatic agents in orthodontics: A review

73

Hemostatic agents versus sutured bolster during laparoscopic partial nephrectomy

74

Hemostatic capability of rapidly curable glues from gelatin, poly(L-glutamic acid), and carbodiimide

75

Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model

76

Hemostatic effects of aprotinin, tranexamic acid and ε-aminocaproic acid in primary cardiac surgery

77

Hemostatic Efficacy of Ankaferd Blood Stopper in a Swine Bleeding Model

78

Hemostatic efficacy of dipyridamole, tranexamic acid, and aprotinin in coronary bypass grafting

79

Hemostatic factors, atherogenesis and atherosclerosis

80

Hemostatic Molecular Markers Before the Onset of Disseminated Intravascular Coagulation

81

Hemostatic parameters in pulmonary tuberculosis patients after intensive phase treatment

82

Hemostatic responses to maximal exercise in oral contraceptive users

83

Hemostatic risk factors of coronary artery disease in the Chinese

84

Hemostatic Role of TachoSil Surgical Patch in Cardiac Surgery

85

Hemostatic state and atrial fibrillation (The Framingham Offspring Study)

86

Hemostatic Tampon to Reduce Bleeding following Tooth Extraction

87

Hemosuccus pancreaticus as a rare cause of gastrointestinal bleeding: a report of two cases.

88

Hemosuccus Pancreaticus in a Patient with Celiac Trunk Aneurysm

89

Hemothorax as the first manifestation of idiopathic pulmonary arteriovenous malformation

90

Hemothorax in type I neurofibromatosis

91

Hemotoxicity of carbon nanotubes

92

Hemotropic Mycoplasmas in Stray Cats in Kerman, Iran

93

Hemoxygenase-1 in Cardiovascular Disease

94

Hemozoin Enhances Maturation of Murine Bone Marrow Derived Macrophages and Myeloid Dendritic Cells

95

Hemp diseases and pests. Management and biological control. An advanced treatise J.M. McPartland, R.C. Clarke and D.P. Watson; CABI Publishing Wallingford, Oxon, price £49.95 (US$90), ISBN 0-85199-454-7

96

Hemp fibre reinforced cashew nut shell liquid composites

97

Hemp fibre reinforced cashew nut shell liquid composites

98

Hemp fibre reinforced composites using chelator and enzyme treatments

99

Hemp Fibres as Novel Green Support Material for Immobilization of Acidithiobacillus ferrooxidans

100

Hemp seed cake in organic broiler diets

101

Hemp seed/evening primrose oil affects expression of STAT3, IL-17, and FOXP3+ in experimental autoimmune encephalomyelitis

102

Hemp: A more sustainable annual energy crop for climate and energy policy

103

HEMP-derived activated carbon fibers by chemical activation with phosphoric acid

104

Hempel S. The Medical Detective: John Snow and the Mystery of Cholera [title in USA ‘The Strange case of the Broad Street Pump] Granta Books, 2006, pp304 ISBN 1-862-07842-4 Hardback £18.99

105

Hempelʹs Raven paradox: a positive approach to cluster analysis

106

Hempseed protein derived antioxidative peptides: Purification, identification and protection from hydrogen peroxide-induced apoptosis in PC12 cells

107

Hemşehrilik and Favouritism in the Context of Political and Civil Society Organizations

108

HEMŞİRELERİN İŞ GÜCÜ VERİMLİLİĞİNİ ETKİLEYEN ÖRGÜTSEL FAKTÖRLER KONUSUNDAKİ TUTUMLARININ BELİRLENMESİ

109

HEMŞİRELERİN ÖRGÜTSEL VATANDAŞLIK DÜZEYLERİNİN BELİRLENMESİ

110

HEMT modelling using semi-physical expressions for the equilibrium space-charge parameters of the modulation-doped heterojunction

111

Hen egg white as a feeder protein for lipase immobilization

112

Hen egg white fractionation by ion-exchange chromatography

113

Hen Egg Yolk Prevents Bacterial Adherence: A Novel Function for a Familiar Food

114

Hen’s egg white hypersensitivity among a group of Egyptian atopic children

115

Hen’s eggshell strength under impact loading Original Research Article

116

HEN-1, a Secretory Protein with an LDL Receptor Motif, Regulates Sensory Integration and Learning in Caenorhabditis elegans

117

Henbit (Lamium amplexicaule L.) control and forage legume tolerance to selected postemergence herbicides

118

Hencky’s logarithmic strain and dual stress–strain and strain–stress relations in isotropic finite hyperelasticity

119

Hendra (Equine Morbillivirus)

120

Hendra virus influences meningoencephalitis-based mortality: A comprehensive review

121

Hendra Virus: A Highly Lethal Zoonotic Agent

122

Hendra-like virus responsible for epidemic in Malaysia

123

He-Ne Laser Irradiation Encourages reparative processes After cartilage loss in New Zealand rabbits

124

HeNe+: resolution of an apparent disagreement between experiment and theory

125

Hengill geothermal volcanic complex (Iceland) characterized by integrated geophysical observations

126

Henipavirus susceptibility to environmental variables

127

Henk F. Moed, Wolfgang Glänzel and Ulrich Schmoch, Editors, Handbook of Quantitative Science and Technology Research: The Use of Publication and Patent Statistics in Studies of S&T Systems, Kluwer Academic Publishers (2004) ISBN 1 4020 2702 8 Hardback (al

128

Henk Postma, 1921–2005

129

Henkelʹs strategy for Asia Pacific

130

Henna, An Antimicrobial Herbal Medicine With Less Negative Effect on Spermatogonial Stem Cell Culture

131

Henney nomination moves forward

132

Henneyʹs FDA nomination on “hold”

133

Hennie Van Greuning, International financial reporting standards — A practical guide (2nd edition), The World Bank, Washington (USA) (2005) ISBN 0-8213-5910-X x+297 p, US$30.00.

134

Henoch Schonlein Purpura in children: clinical analysis of 120 cases

135

Henoch–Sch ̈onlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management

136

Henoch-Schoenlein Purpura Following Severe Acute Respiratory Syndrome Coronavirus-2 Infection: A Case Report

137

Henoch-Schönlein purpura

138

Henoch-Schonlein Purpura Associated with Methicillin-Resistant Staphylococcus aureus Infection

139

Henoch-Schonlein Purpura in A Child Complicated by Fatal Pulmonary Hemorrhage

140

Henoch-Schonlein Purpura in an Elderly Women Presenting with Severe GI Bleeding: A case report

141

Henoch-Schonlein purpura in children

142

Henoch-Schonlein Purpura in Northeast India: Peculiarities in Presentation

143

Henoch-Schönlein purpura with intracerebral hemorrhage

144

Henoch-Schönlein syndrome induced by carbidopa/levodopa

145

Hénon–Heiles potential as a bridge between nontopological solitons of different types

146

HENOSEPILACHNA SEPTIMA DIEKE (COCCINELLIDAE; COLEOPTERA); A NEW RECORD FOR PAKISTAN ALONG WITH NOTES ON ITS TAXONOMY, HOST PLANTS AND DISTRIBUTION

147

HENOSEPILACHNA VIGINTIOCTOPUNCTATA (FAB.) (EPILACHNINAE; COCCINELLIDAE); ITS TAXONOMY, DISTRIBUTION AND HOST PLANTS IN PAKISTAN.

148

Henri Theil, 1924–2000

149

Henri Wallonʹs Theory of Early Child Development: The Role of Emotions

150

Henrian ideality of iron in liquid uranium solvent at high temperatures

151

Henriciʹs transformation and its application to the computation of derivatives of eigensystems

152

Henricus Mattheus Princen

153

Henrik Kacser (1918–1995): an Annotated Bibliography

154

155

Henriksen and Isbell on f-rings

156

Henriksenʼs contributions to residue class rings of analytic and entire functions

157

Henry Adams and the question of posthistoire

158

Henry Arthur Solomon, MD: a conversation with the editor

159

Henry Bowditch and “The Young Stethoscopist”

160

Henry condensations with 4,6-O-benzylidenylated and non-protected d-glucose and l-fucose via DBU-catalysis

161

Henry Darger: Art and Selected Writings: Michael Bonesteel;Rizzoli International Publications, Inc., New York, 2000, 256 pages, 125 color illustrations; hardbound, $85

162

Henry Hobson Richardson and the small public library in America: A study in topology : Breisch, Kenneth A. Cambridge, MA: MIT Press, 1997. 343 pp. $50.00. ISBN: 0-262-2416-0

163

Henry Hugh Higgins and Frederick Price Marrat: the reluctant palaeobotanists and the Ravenhead collection

164

Henry James and the New Woman: A Feminist Reading of The Bostonians

165

Henry kempe memorial lecture—10th International congress on child abuse and neglect : Child abuse and neglect from an indigenous Australianʹs perspective

166

Henry reaction of fluorinated nitro compounds

167

Henry S. Kaplan Distinguished Scientist Award 2003

168

Henry Swan II, MD

169

Henry Swan II, MD

170

Henry Vartan Kehiaian (1929–2009)

171

Henry W. Lane, Martha L. Maznevski, Mark E. Mendenhall and Jeanne McNett, Editors, The Blackwell Handbook of Global Management: A Guide to Managing Complexity, Blackwell Publishers, Malden, MA (2004).

172

Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).

173

Henry, C.J.K. (Ed.) Novel food ingredients for weight control, Woodhead Publishing Ltd., Cambridge, UK, 2007 (xiv + 358 pp., £135.00, ISBN 1-84569-030-4).

174

Henry’s constants of butane, isobutane, 1-butene and isobutene in methanol at 255–320 K

175

Henry’s constants of carbon dioxide in methanol at 250–500 K

176

Henry’s constants of methanol in aqueous systems containing salts

177

Henry’s law constant measurements for formaldehyde and benzaldehyde as a function of temperature and water composition

178

Henry’s law constant, octanol–air partition coefficient and supercooled liquid vapor pressure of carbazole as a function of temperature: Application to gas/particle partitioning in the atmosphere

179

Henry’s law constants and isosteric heats of adsorption at zero loading for multi-wall carbon surfaces with different geometries Original Research Article

180

Henry’s law constants and mass transfer coefficients for methyl bromide and 1,3-dichloropropene applied to Florida sandy field soil

181

Henry’s law constants derived from equilibrium static cell measurements for dilute organic–water mixtures

182

Henry’s law constants for hexachlorobenzene, p,p′-DDE and components of technical chlordane and estimates of gas exchange for Lake Ontario

183

Henry’s law constants of methane, nitrogen, oxygen and carbon dioxide in ethanol from 273 to 498 K: Prediction from molecular simulation

184

Henry’s law constants of phenol and mononitrophenols in water and aqueous sulfuric acid Original Research Article

185

Henry–Nef reaction: a practical and versatile chiral pool route to 2-substituted pyrrolidine and piperidine alkaloids

186

Henryʹs constants of gases and volatile organic compounds in aqueous solutions

187

Henryʹs constants of n-alkanols (methanol through n-hexanol) in water at temperatures between 40°C and 90°C

188

Henryʹs constants of propane, propene, trans-2-butene and 1,3-butadiene in methanol at 255–320 K

189

Henryʹs Law and the solubilities of reactant gases in the modelling of PEM fuel cells

190

Henryʹs Law coefficients of chloropicrin and methyl isothiocyanate

191

Henryʹs law constant and related coefficients for aqueous hydrocarbons, CO2 and H2S over a wide range of temperature and pressure

192

Henryʹs law constant measurements for phenol, o-, m-, and p-cresol as a function of temperature

193

Henryʹs law constants and hydrolysis rate constants of 2,2,2-trifluoroethyl acetate and methyl trifluoroacetate

194

Henryʹs law constants for a diverse set of organic chemicals: Experimental determination and comparison of estimation methods

195

Henryʹs law constants for C2–C3 fluorinated alcohols and their wet deposition in the atmosphere

196

Henryʹs law constants for α-, β-, and γ-hexachlorocyclohexanes (HCHs) as a function of temperature and revised estimates of gas exchange in Arctic regions

197

Henryʹs law constants measurements of alachlor and dichlorvos between 283 and 298 K

198

Henryʹs law constants measurements of the nonylphenol isomer 4(3′,5′-dimethyl-3′-heptyl)-phenol, tertiary octylphenol and γ-hexachlorocyclohexane between 278 and 298 K

199

Henryʹs law constants of 1-butene, 2-methylpropene, trans-2-butene, and 1,3-butadiene in methanol at 374–490 K

200

Henryʹs law constants of 2,2,2-trifluoroethyl formate, ethyl trifluoroacetate, and non-fluorinated analogous esters

201

Henryʹs law constants of halogenated organic acids

202

Henryʹs law constants of propane, propene, butane, and 2-methylpropane in methanol at 374–490 K

203

Hens are motivated to dustbathe in peat irrespective of being reared with or without a suitable dustbathing substrate

204

Hens’ welfare to egg quality: a European perspective

205

Hensel′s Lemma and the Divisibility by Primes of Stirling-like Numbers Original Research Article

206

Henselian residually p-adically closed fields

207

Henselian Valued Stable Fields

208

Hensleyʼs problem for complex and non-Archimedean meromorphic functions

209

Henstock type integral in harmonic analysis on zero-dimensional groups

210

Henstock–Kurzweil delta and nabla integrals ✩

211

Henstock–Kurzweil–Pettis integrability of compact valued multifunctions with values in an arbitrary Banach space

212

Henstockʹs multiple wiener integral and henstockʹs version of hu-meyer theorem

213

heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi

214

heoretical studies on shuttle checking: Part II-Shuttle checking by swell P K Hari K N Gupta B K Behera S G Joshi

215

heory of Markov systems with fuzzy states

216

Hep atop rotective Potentials of Ghrelin and/or N-Acetyl Cysteine in Thioacetamide Induced Chronic Liver Injury in Rats

217

Hep atop rotective Role for Querectin in Diabetic Rats: Hypolipidemic and Antioxidant Effects

218

HEP computing in Korea Original Research Article

219

HEp-2 cell classification using rotation invariant co-occurrence among local binary patterns

220

HEp-2 cell image classification with multiple linear descriptors

221

HEp-2 cell pattern classification with discriminative dictionary learning

222

HEp-2 cells classification via sparse representation of textural features fused into dissimilarity space

223

HEp-2 fluorescence pattern classification

224

HEp-2 image classification using intensity order pooling based features and bag of words

225

HEPACAM1 and 2 are differentially regulated in canine mammary adenomas and carcinomas and its lymph node metastases

226

Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks

227

Heparan sulfate abnormalities in exostosis growth plates

228

Heparan sulfate is the main sulfated glycosaminoglycan species in internal organs of the male cockroach, Periplaneta americana

229

Heparan sulfate isomers in cerebral arteries of Japanese women with aging and with atherosclerosis—heparitinase and high-performance liquid chromatography determinations

230

Heparan sulfate proteoglycans. Essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall Original Research Article

231

Heparan Sulfate: A Complex Polymer Charged with Biological Activity

232

Heparan sulphate proteoglycans in Alzheimerʹs disease and amyloid-related disorders

233

Heparanase expression and activity influences chondrogenic and osteogenic processes during endochondral bone formation

234

Heparanase expression in human leukemias is restricted to acute myeloid leukemias

235

Heparanase Gene Hypomethylation as a Potential Biomarker for Precision Screening of Bladder Cancer

236

Heparanase promotes bone destruction and invasiveness in prostate cancer

237

Heparanase Regulates Thrombosis in Vascular Injury and Stent-Induced Flow Disturbance

238

Heparanase, heparan sulfate and perlecan distribution along with the vascular penetration during stellate reticulum retraction in the mouse enamel organ

239

Heparan-like molecules induce the repair of skull defects

240

Heparin accelerates liver regeneration following portal branch ligation in normal and cirrhotic rats with increased plasma hepatocyte growth factor levels

241

Heparin Activates PKR by Inducing Dimerization

242

Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood

243

Heparin after percutaneous intervention (HAPI): prospective multicenter randomized trial of three heparin regimens after successful coronary intervention

244

Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure

245

Heparin and aspirin in stroke

246

Heparin and aspirin in stroke

247

Heparin and aspirin in unstable angina: Insufficient sample size may lead to erroneous conclusions

248

Heparin and inflammatory bowel disease

249

Heparin and its derivatives in the treatment of arterial thrombosis: a review

250

Heparin and Low Molecular Weight Heparin Decrease Nitric Oxide Production by Human Polymorphonuclear Cells

251

heparin and platelet function

252

Heparin and the nonanticoagulant N-acetyl heparin attenuate capillary no-reflow after normothermic ischemia of the lung

253

Heparin antiproliferative activity on bovine pulmonary artery smooth muscle cells requires both N-acetylation and N-sulfonation Original Research Article

254

Heparin as adjunctive therapy to coronary thrombolysis in acute myocardial infarction

255

Heparin as an adjuvant to thrombolytic therapy in acute myocardial infarction

256

Heparin attenuates cytotoxic and inflammatory activity of Alzheimer amyloid-β in vitro

257

Heparin binding activity of orf virus F1L protein

258

Heparin Binding and Augmentation of C1 Inhibitor Activity

259

Heparin Binds to the Laminin α4 Chain LG4 Domain at a Site Different from that Found for Other Laminins

260

Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass

261

Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass

262

Heparin Causes the Accumulation of Heparan Sulfate in Cultures of Arterial Smooth Muscle Cells

263

Heparin coated Palmaz-Schatz™ stents are highly thrombo-resistant: baboon A-V shunt study

264

Heparin coated poly(alkylcyanoacrylate) nanoparticles coupled to hemoglobin: a new oxygen carrier

265

Heparin coating dramatically reduces platelet deposition on incompletely deployed Palmaz-Schatz™ in the baboon A-V shunt

266

Heparin coating of bypass systems

267

Heparin coating of poly(ethylene terephthalate) decreases hydrophobicity, monocyte/leukocyte interaction and tissue interaction

268

Heparin coating of the stent graft — effects on platelets, coagulation and complement activation

269

Heparin Coating With Aprotinin Reduces Blood Activation During Coronary Artery Operations

270

Heparin cofactor II (RbHCII) from rock bream (Oplegnathus fasciatus): Molecular characterization, cloning and expression analysis

271

Heparin column analysis of serum type 5 tartrate-resistant acid phosphatase isoforms

272

Heparin conjugated silica nanoparticle synthesis

273

Heparin coupling in inhibition of calcification of vascular bioprostheses

274

Heparin crosslinked chitosan microspheres for the delivery of neural stem cells and growth factors for central nervous system repair

275

Heparin delivery at the site of angioplasty with a nevel drug delivery sleeve

276

Heparin dosing and outcome in acute coronary syndromes: The GUSTO-IIb experience

277

Heparin effect on platelets and fibrinolysis

278

Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity

279

Heparin for acute ischaemic stroke: a never-ending story?

280

Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation

281

Heparin in acute coronary syndromes

282

Heparin in calcification prevention of porcine pericardial bioprostheses

283

Heparin in sepsis treatment

284

Heparin in sepsis treatment – Authorsʹ reply

285

Heparin in the treatment of burns: a review

286

Heparin in unstable angina

287

Heparin incorporating liposomes as a delivery system of heparin from PET-covered metallic stents: Effect on haemocompatibility

288

Heparin- induced thrombocytopenia (HIT): a case report of CABG patient

289

Heparin Infusion Prior to Stenting (HIPS) trial: Final results of a prospective, randomized, controlled trial evaluating the effects of local vascular delivery on intimal hyperplasia

290

Heparin Initiation Before and After Femoral Arterial Access in Primary Percutaneous Coronary Intervention: Side Effects and Angiographic Success Rates

291

Heparin intercalation into reconstituted collagen I fibrils: Impact on growth kinetics and morphology

292

Heparin interference in whole blood sodium measurements in a pediatric setting

293

Heparin Is More Effective Than Inogatran, a Low-Molecular Weight Thrombin Inhibitor in Suppressing Ischemia and Recurrent Angina in Unstable Coronary Disease

294

Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation

295

Heparin potentiates collateral growth but not growth of intramyocardial endarteries in dogs with repeated coronary occlusion

296

Heparin preserves nitric oxide activity in coronary endothelium during ischemia-reperfusion injury

297

Heparin prophylaxis in bedridden patients

298

Heparin receptors in two murine mammary adenocarcinomas with different metastatic ability: relationship with growth inhibition

299

Heparin Resistance During and Post-Intravenous Nitroglycerin Infusion

300

Heparin Reverses Anaphylactoid Shock in a Porcine Model

301

Heparin reverses Rhodamine 123 extrusion by multidrug resistant cells

302

Heparin study sparks controversy among cardiologists

303

Heparin therapy for deep vein thrombosis: from hospital to home

304

Heparin therapy in electrical burns: First study and pictures

305

Heparin Thromboprophylaxis for Medical Inpatients

306

Heparin use complicates cardiological procedures

307

Heparin versus aspirin in ischaemic stroke

308

Heparin versus aspirin in ischaemic stroke

309

Heparin versus aspirin in ischaemic stroke

310

Heparin vs aspirin in acute ischaemic stroke

311

Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease

312

Heparin, Enoxaparin, and Mechanical Prophylaxis Utilization Evaluation in DVT Prophylaxis in a Major Teaching Hospital in West of Iran

313

Heparinase-II-Catalyzed Degradation of N-Propionylated Heparin

314

Heparin-binding activity of feline herpesvirus type 1 glycoproteins

315

Heparin-binding EGF-like growth factor induces expression of lectin-like oxidized LDL receptor-1 in vascular smooth muscle cells

316

Heparin-bonded circuits decrease myocardial ischemic damage

317

Heparin-Bonded Circuits Decrease Myocardial Ischemic Damage: An Experimental Study

318

Heparin-bonded circuits with a reduced anticoagulation protocol in primary CABG: a prospective, randomized study

319

Heparin-Bonded Covered Stents Versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis With PROPATEN Bioactive Surface [VIA] Versus Bare Nitinol Stent in the Treatment of Long Lesions in Sup

320

Heparin-bonded surfaces in extracorporeal membrane oxygenation for cardiac support

321

Heparin-coated bypass circuits in cardiopulmonary bypass: Improved biocompatibility or not

322

Heparin-coated bypass circuits: effects on inflammatory response in pediatric cardiac operations

323

Heparin-coated circuits and aprotinin prime for coronary artery bypass grafting

324

Heparin-coated circuits and reduced systemic anticoagulation applied to 2500 consecutive first-time coronary artery bypass grafting procedures

325

Heparin-coated circuits for high-risk patients: a multicenter, prospective, randomized trial

326

Heparin-coated circuits reduce myocardial injury in heart or heart-lung transplantation: a prospective, randomized study

327

Heparin-Coated Equipment Reduces the Risk of Oxygenator Failure

328

Heparin-coated Wiktor stents in human coronary arteries (MENTOR Trial)

329

Heparin-conjugated scaffolds with pore structure of inverted colloidal crystals for cartilage regeneration

330

Heparin-decorated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2

331

Heparin-doped affinity electromembranes for thrombin purification

332

Heparin-folate-retinoic acid bioconjugates for targeted delivery of hydrophobic photosensitizers

333

Heparin-free hemodialysis in the treatment of hypernatremia in severely burned patients

334

Heparin-functionalized chitosan scaffolds for bone tissue engineering Original Research Article

335

Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications

336

Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents

337

Heparin-independent mitogenicity in an endothelial and smooth muscle cell chimeric growth factor (S130K-HBGAM)

338

Heparin-induced aldosterone suppression and hyperkalemia

339

Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis

340

Heparin-Induced Cancer Cell Death Review Article

341

Heparin-induced CVA

342

Heparin-induced hyperkalemia after cardiac surgery

343

Heparin-induced platelet dysfunction and cardiopulmonary bypass

344

Heparin-Induced Thrombocytopeni

345

Heparin-induced thrombocytopenia

346

Heparin-induced thrombocytopenia and cardiac surgery

347

Heparin-induced thrombocytopenia and cardiac surgery

348

Heparin-induced thrombocytopenia and cardiopulmonary bypass: perioperative argatroban use

349

Heparin-induced thrombocytopenia and cardiovascular diseases

350

Heparin-induced thrombocytopenia and heart operation: Management with tedelparin

351

Heparin-Induced Thrombocytopenia Associated With Bilateral Adrenal Hemorrhage After Coronary Artery Bypass Surgery

352

Heparin-induced thrombocytopenia in coronary bypass surgery

353

Heparin-Induced Thrombocytopenia in Left Ventricular Assist Device Bridge-to-Transplant Patients

354

Heparin-induced thrombocytopenia in the emergency department

355

Heparin-induced thrombocytopenia is rare in pregnancy

356

Heparin-induced thrombocytopenia with thrombotic sequelae: a review

357

Heparin-induced thrombocytopenia: an overview

358

Heparin-induced thrombocytopenia: bovine versus porcine heparin in cardiopulmonary bypass surgery

359

Heparin-induced thrombocytopenia: clinical manifestations and management strategies

360

Heparinization of gas plasma-modified polystyrene surfaces and the interactions of these surfaces with proteins studied with surface plasmon resonance

361

Heparinized and Saline Solutions in the Maintenance of Arterial and Central Venous Catheters After Cardiac Surgery

362

Heparinized bovine pericardium as a novel cardiovascular bioprosthesis

363

Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance

364

Heparin-like anticoagulant activity of sulphonated poly(ethylene oxide) and sulphonated poly(ethylene oxide)-grafted polyurethane

365

Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5

366

Heparin-like functionalized polymer surfaces: discrimination between catalytic and adsorption processes during the course of thrombin inhibition

367

Heparinoid Anticoagulation and Topical Fibrin Sealant in Heparin-Induced Thrombocytopenia

368

Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum

369

Heparinoid-active two sulfated polysaccharides isolated from marine green algae Monostroma nitidum

370

Heparin–platelet factor 4 antibodies in patients presenting to the ED with thrombosis

371

Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF

372

Heparin-related thrombosis despite normal platelet counts in vascular surgery

373

Heparin-released extracellular superoxide dismutase is reduced in patients with coronary artery atherosclerosis

374

Heparins in management of acute coronary syndromes without ST-segment elevation

375

Heparin-stimulated expression of extracellular-superoxide dismutase in human fibroblasts

376

Hepatectomy for liver metastases from breast cancer

377

Hepatectomy using traditional Péan clamp–crushing technique under intermittent Pringle maneuver

378

Hepatic “split lesion” in a fatal electrocution case

379

Hepatic “Stem” Cells: Coming Full Circle

380

Hepatic 18F-FDG Uptake Measurements on PET/MR: Impact of Volume of Interest Location on Repeatability

381

Hepatic 5′-AMP-Activated Protein Kinase: Zonal Distribution and Relationship to Acetyl-CoA Carboxylase Activity in Varying Nutritional States

382

Hepatic 7-ethoxyresorufin O-deethylase Activity in eel (Anguilla Anguilla) from The Thames Estuary and Comparisons with other United Kingdom Estuaries

383

Hepatic abscess caused by Brucella US, CT and MRI findings: Case report and review of the literature

384

Hepatic activities of CYP1A and thiamine-dependent enzymes in Baltic salmon (Salmo salar) alevins suffering from the thiamine deficiency M74

385

Hepatic Acyl CoA Oxidase1 Inhibition Modifies Brain Lipids and Electrical Properties of Dentate Gyrus

386

Hepatic adenoma and focal nodular hyperplasia: mr findings with superparamagnetic iron oxide– enhanced mri

387

Hepatic adenomatosis: MRI demonstration with the use of superparamagnetic iron oxide

388

Hepatic allograft abscess with hepatic arterial thrombosis

389

Hepatic Alterations in the Amphibian Sclerophrys regularis as Biomarkers for Habitat Destruction

390

Hepatic alterations in the fish Rhamdia quelen contaminated with Folidol 600®

391

Hepatic Alveolar Echinococcosis

392

Hepatic alveolar echinococcosis: MRI findings

393

Hepatic Alveolar Hydatid Cyst: A Brief Review of Published Cases from Iran in the Last 20 Years

394

Hepatic amino acid and protein metabolism in non-anorectic, moderately cachectic tumor-bearing rats

395

Hepatic amino nitrogen conversion and organ N-contents in hypothyroidism, with thyroxine replacement, and in hypethyroid rats

396

Hepatic amino- to urea-N clearance and forearm amino-N exchange during hypoglycemic and euglycemic hyperinsulinemia in normal man

397

Hepatic anaplerotic outflow fluxes are redirected from gluconeogenesis to lactate synthesis in patients with Type 1a glycogen storage disease

398

Hepatic and biliary biomarkers in rainbow trout injected with sediment extracts from the River Po (Italy)

399

Hepatic and extrahepatic dehydrogenation/isomerization of 5-cholestene-3β,7α-diol: localization of 3β-hydroxy-Δ5-C27-steroid dehydrogenase in pig tissues and subcellular fractions

400

Hepatic and extrahepatic malignancies in primary sclerosing cholangitis

401

Hepatic and Extra-hepatic Transcription of Inter-α-inhibitor Family Genes under Normal or Acute Inflammatory Conditions in Rat

402

Hepatic and intestinal cytochrome P450 and conjugase activities in rats treated with black tea theafulvins and theaflavins

403

Hepatic and Intestinal Schistosomiasis: Review

404

Hepatic and renal concentrations of 10 trace elements in crocodiles (Crocodylus niloticus) in the Kafue and Luangwa rivers in Zambia

405

Hepatic and renal concentrations of vitamins E and C in lead- and ethanol-exposed rats. An assessment of their involvement in the mechanisms of peroxidative damage

406

Hepatic and renal metallothionein induction by an oral equimolar dose of zinc, cadmium or mercury in mice

407

Hepatic and skeletal muscle glycogen metabolism in rats with short-term cholestasis

408

Hepatic and splenic sarcoidosis as a cause of hypercalcemia: a case report

409

Hepatic angiomyolipoma with minimal fat content: MR demonstration

410

Hepatic Angiomyolipoma: a Rarely Described Tumor

411

Hepatic angiomyolipoma: Demonstration by out of phase MRI

412

Hepatic angiomyolipoma: Value of proton (fat/water) chemical shift fast low angle shot (FLASH) MR imaging technique in detecting fatty tissue content

413

HEPATIC ANGIOSARCOMA: REPORT OF A CASE WITHOUT A HISTORY OF EXPOSURE TO ENVIRONMENTAL RISK FACTORS

414

Hepatic antioxidant enzymes and total glutathione of Cyprinus carpio exposed to three disinfectants, chlorine dioxide, sodium hypochlorite and peracetic acid, for superficial water potabilization

415

HEPATIC ANTIOXIDANT, OXIDATIVE STRESS an‎d HISTOPATHOLOGICAL CHANGES INDUCED BY NICOTINE IN A GENDER BASED STUDY IN ADULT RATS

416

Hepatic apolipoprotein and LDL receptor gene expression in the genetically hypercholesterolemic (RICO) rat Original Research Article

417

Hepatic Arterial Blood Flow Index Is Associated with the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B Virus Infection

418

Hepatic arterial blood flow velocities: assessment by transcutaneous and intravascular Doppler sonography

419

Hepatic arterial Fotemustine chemotherapy in patients with liver metastases from cutaneous melanoma is as effective as in ocular melanoma

420

Hepatic arterial infusion chemotherapy for metastatic colorectal cancer: a concise overview

421

Hepatic Arterial Infusion Chemotherapy with Cisplatin for TACE-Refractory or -Ineligible Hepatocellular Carcinoma with Child-Pugh Score of 8 or Above

422

Hepatic arterial infusion for hepatic metastases from Colon Cancer

423

Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi

424

Hepatic arterial injection chemotherapy for hepatocellular carcinoma with epirubicin aqueous solution as numerous vesicles in iodinated poppy-seed oil microdroplets: clinical application of water-in-oil-in-water emulsion prepared using a membrane emulsifi

425

Hepatic arterial pulsatility index in cirrhosis: correlation with portal pressure

426

Hepatic Artery and Portal Vein Doppler Indexes in Non‑alcoholic Fatty Liver Disease Before and After Treatment to Prevent Unnecessary Health Care Costs

427

Hepatic Artery Aneurysms as a Rare but Important Cause of Abdominal Pain; a Case Series

428

Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors

429

Hepatic artery chemotherapy and colorectal liver metastases

430

Hepatic artery chemotherapy and colorectal liver metastases

431

Hepatic artery chemotherapy and colorectal liver metastases

432

Hepatic artery chemotherapy and colorectal liver metastases

433

Hepatic artery embolisation with a novel radiopaque polymer causes extended liver necrosis in pigs due to occlusion of the concomitant portal vein

434

Hepatic artery infusion for liver metastases from colorectal cancer

435

Hepatic artery infusion of high-dose melphalan at reduced flow during isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: A clinical and pharmacologic evaluation

436

Hepatic artery ligation: a simple and safe technique to treat extrahepatic aneurysms of the hepatic artery

437

Hepatic artery malformations associated with a primary defect in intrahepatic bile duct development

438

Hepatic Artery Pseudoaneurysm ; Simple or Difficult to Diagnose

439

Hepatic artery pseudoaneurysm; a rare complication of Amoebic liver abscess

440

Hepatic Basolateral Plasma High-affinity Ca2+-RATPase is Inhibited by Nitric Oxide and Peroxynitrite Anion

441

Hepatic bile salt flux does not modulate level and activity of the sinusoidal Na+-taurocholate cotransporter (ntcp) in rats

442

Hepatic binding proteins translocating azo dye carcinogen metabolites from cytoplasm into nucleus in rats

443

Hepatic biomarkers of sediment-associated pollution in juvenile turbot, Scophthalmus maximus L.

444

Hepatic biomarkers of xenobiotic metabolism in eighteen marine fish from NW Mediterranean shelf and slope waters in relation to some of their biological and ecological variables

445

Hepatic biotransformation of alkylresorcinols is mediated via cytochrome P450 and β-oxidation: A proof of concept study

446

Hepatic bisegmentectomy 7–8 for a colorectal metastasis

447

Hepatic blood flow and splanchnic oxygen consumption in patients with hepatic encephalopathy before and after high-volume plasmapheresis

448

Hepatic blood flow responses to mechanical stimulation of the skin in anaesthetised rats

449

Hepatic branch vagotomy can block liver regeneration enhanced by ursodesoxycholic acid in 66% hepatectomized rats

450

HEPATIC CAPILLARIASIS IN CHILDREN: REPORT OF 3 CASES IN BRAZIL

451

Hepatic cavernous hemangiomas: Patterns of contrast enhancement on MR fluoroscopy imaging

452

Hepatic cell-specific ATP-binding cassette (ABC) transporter profiling identifies putative novel candidates for lipid homeostasis in mice

453

Hepatic cellular and tissue pathologic response in the mosquito fish, Gambusia affinis, to different time exposure of diethylnitrosamine

454

Hepatic Changes in the Freeze-Tolerant Turtle Chrysemys picta marginata in Response to Freezing and Thawing

455

Hepatic Choristoma: an Unexpected Finding During Cholecystectomy

456

Hepatic clearance of advanced glycation end products (AGEs)—myth or truth?

457

Hepatic CYP1A in winter flounder (Pleuronectes americanus) along the Northeast Coast: Results from the national benthic surveillance project

458

Hepatic CYP1A levels and EROD activity in English sole: biomonitoring of marine contaminants in Vancouver Harbour

459

Hepatic CYP450 gene expression, hematological and biochemical indices in Caspian roach (Rutilus caspius) induced by Endosulfan

460

Hepatic cytochrome P450 is directly inactivated by nitric oxide, not by inflammatory cytokines, in the early phase of endotoxemia

461

Hepatic cytochrome P450 reductase-null mice reveal a second microsomal reductase for squalene monooxygenase

462

Hepatic cytochrome P4501A and 7-ethoxyresorufin O-deethylase induction in mullet and common sole as an indicator of toxic organic pollution in Izmir Bay, Turkey

463

Hepatic differentiation of porcine induced pluripotent stem cells in vitro

464

Hepatic DNA adducts and production of mutagenic urine in 2,6-dinitrotoluene-treated B6C3F, male mice

465

Hepatic duct diverticulum

466

Hepatic dysfunction after left ventricular mechanical assist in patients with end-stage heart failure: role of inflammatory response and hepatic microcirculation

467

Hepatic dysfunction associated with atenolol

468

Hepatic Dysfunction in Ambulatory Patients With Heart Failure: Application of the MELD Scoring System for Outcome Prediction

469

Hepatic dysfunction in critically ill patients

470

Hepatic Effects of Endothelin: Metabolism of [125I]Endothelin-1 by Liver-Derived Cells

471

Hepatic elemental contents and antioxidant enzyme activities in Algerian mice (Mus spretus) inhabiting a mine area in central Portugal

472

Hepatic encephalopathy and ascites

473

Hepatic encephalopathy and ascites

474

Hepatic encephalopathy and nitric oxide

475

Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?

476

Hepatic Encephalopathy Linked to COVID-19 in a Pediatric Case: A Rare Presentation of COVID-19

477

Hepatic encephalopathy: Clinical aspects and pathogenetic concept

478

Hepatic Encephalopathy: Early Diagnosis in Pediatric Patients With Cirrhosis

479

Hepatic Energy and Substrate Metabolism: A Possible Metabolic Basis for Early Nutritional Support in Cirrhotic Patients

480

Hepatic environment elicits monocyte differentiation into a dendritic cell subset directing Th2 response

481

Hepatic Epithelioid Hemangioendothelioma: A Review of Three Liver Transplant Recipients

482

Hepatic EROD Activity in Flounder (Platichthys flesus) as an Indicator of Contaminant Exposure in English Estuaries

483

Hepatic ethoxyresorufin O-deethylase (EROD) activity in flounder (Platichthys flesus) from contaminant impacted estuaries of the United Kingdom: continued monitoring 1999–2001

484

Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases

485

Hepatic expression of regeneration marker genes following partial hepatectomy in the rat : Influence of 1,25-dihydroxyvitamin D3 in hypocalcemia

486

Hepatic expression profiling in smolting and adult coho salmon (Onchorhynchus kisutch)

487

Hepatic Failure After Bariatric Surgery: A Systematic Review

488

Hepatic Failure in a Young Woman Following Ingestion of Tribulus Terrestris

489

Hepatic Failure Related to Itraconazole Use Successfully Treated by Corticosteroids

490

Hepatic fatty acid metabolism in rats fed diets with different contents of C18 : 0, C18 : 1 cis and C18 : 1 trans isomers

491

Hepatic focal nodular hyperplasia in infant antenatally exposed to steroids

492

Hepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways

493

Hepatic fructose-metabolizing enzymes and related metabolites: role of dietary copper and gender

494

Hepatic functional reserve in patients with obstructive jaundice: An assessment by the redox tolerance test

495

Hepatic gene expression and lipid parameters in complement C3−/− mice that do not develop ethanol-induced steatosis

496

Hepatic gene expression and plasma albumin concentration related to outcome after attenuation of a congenital portosystemic shunt in dogs

497

Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients

498

Hepatic gene expression profile associated with non-alcoholic steatohepatitis protection by S-nitroso-N-acetylcysteine in ob/ob mice

499

Hepatic gene expression profile in brown trout (Salmo trutta) exposed to traffic related contaminants Original Research Article

500

Hepatic gene expression profiling reveals perturbed calcium signaling in a mouse model lacking both LDL receptor and Apobec1 genes

501

Hepatic gene induction in murine bone marrow after hepatectomy

502

Hepatic glucose metabolism in humans—its role in health and disease

503

Hepatic glucose output response to nicotine and the underlying neural mechanism in rats

504

Hepatic Glutamate Dehydrogenase Activity and the Presence of Ammonia and Urea in the Circulatory Fluid of Channa Gachua in WaterRestricted Condition

505

Hepatic glutaminase—a special role in urea synthesis?

506

Hepatic glutamine metabolism

507

Hepatic glutamine metabolism during endotoxemia in neonatal rats

508

Hepatic glutathione in English sole (Pleuronectes vetulus): Response to complex mixtures of xenobiotics

509

Hepatic glutathione S-transferase activity in flounder collected from contaminated and reference sites along the Polish coast

510

Hepatic glutathione S-transferases from lamprey (Petromyzom marinus): purification and characterization

511

Hepatic granuloma mimicking recurrent lymphoma on ^18F-FDG PET/CT in a patient with primary mediastinal diffuse large B-cell lymphoma

512

Hepatic granulomas associated with brucellosis

513

Hepatic Health and Humoral Immunological Parameters of Common Carp (Cyprinus carpio) Fed Lactic Acid-supplemented Diets

514

Hepatic hemosiderosis in buffalo fish (Ictiobus spp.)

515

Hepatic histology in obese patients undergoing bariatric surgery

516

Hepatic histopathology in two populations of the mummichog, Fundulus heteroclitus

517

Hepatic hyaline globules in an Eclectus parrot (Eclectus roratus)

518

Hepatic hydatid cyst presenting as a cutaneous fistula

519

HEPATIC HYDROTHORAX WITH MODERATE ASCITIS IN A NIGERIAN

520

Hepatic hydrothorax: pathogenesis, diagnosis, and management

521

Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count), ,

522

Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infection

523

Hepatic Impact of Different Concentrations of Hibiscus rosa Zinc Oxide Nanoparticles on Rats

524

Hepatic inflammatory mass secondary to toothpick perforation of the stomach: triphasic CT appearances

525

Hepatic injury and vitamin A ingestion

526

Hepatic Involvement and Association with Prognosis in COVID-19 Patients: A Single-Centre Report from Iran

527

Hepatic Involvement in Dengue Fever in Children

528

Hepatic iron concentration does not predict response to standard and pegylated-IFN/ribavirin therapy in patients with chronic hepatitis C

529

Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del “loss of function” mutations in ferroportin disease

530

Hepatic iron metabolism gene expression profiles in HFE associated Hereditary Hemochromatosis

531

Hepatic iron overload and fibrosis in patients with beta thalassemia major after hematopoietic stem cell transplantation: A pilot study.

532

Hepatic iron overload and hepatocellular carcinoma

533

Hepatic iron overload in alcoholic liver disease: why does it occur and what is its role in pathogenesis?

534

Hepatic iron status and response to therapy in chronic viral hepatitis B and C: A preliminary report

535

Hepatic Ischemia and Reperfusion Injury and Trauma: Current Concepts

536

Hepatic ischemia secondary to hepatic artery ligation: MRI findings

537

Hepatic Ischemia/Reperfusion Injury Is Diminished by Atorvastatin in Wistar Rats

538

Hepatic ischemia-reperfusion injury

539

Hepatic ischemia-reperfusion injury

540

Hepatic levels of metal and metallothioneins in two commercial fish species of the Northern Iberian shelf

541

Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture Original Research Article

542

Hepatic lipase mediates lipoprotein uptake into cells via LDL receptor-related protein

543

Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: The Copenhagen City Heart Study

544

Hepatic lipase promoter activity is reduced by the C-480T and G-216A substitutions present in the common LIPC gene variant, and is increased by Upstream Stimulatory Factor

545

Hepatic lipase promoter C-514T polymorphism influences serial changes in HDL cholesterol levels since childhood: the Bogalusa Heart Study

546

Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice

547

Hepatic lipid composition analysis using 3.0-T MR spectroscopy in a steatotic rat model

548

Hepatic lipidosis in a common Mynah (Acridotheres tristis) associated with pododermatitis and consumption of broiler pelleted feed

549

Hepatic lipogenic enzyme expression in pigs is affected by selection for decreased backfat thickness at constant intramuscular fat content

550

Hepatic Lobectomy-Case Report of Two Patients, Performed at Chittagong Medical College Hospital

551

Hepatic localisation of rat cysteine dioxygenase

552

Hepatic mesenchymal hamartoma with translocation involving chromosome band 19q13.4: a recurrent abnormality

553

Hepatic metabolism of sulfur amino acids in db/db mice

554

Hepatic metabolism, phase I and II biotransformation enzymes in Atlantic salmon (Salmo Salar, L) during a 12 week feeding period with graded levels of the synthetic antioxidant, ethoxyquin

555

Hepatic metallothionein as a biomarker for metal contamination: age effects and seasonal variation in European flounders (Pleuronectes flesus) from the Severn Estuary and Bristol Channel

556

Hepatic metallothionein concentrations in the golden grey mullet (Liza aurata) – Relationship with environmental metal concentrations in a metal-contaminated coastal system in Portugal

557

Hepatic metastasis complicated by abscess formation

558

Hepatic Microcirculatory Changes Induced by Hepatic Artery Embolization in Rats Original Investigation

559

Hepatic microvascular features in experimental cirrhosis: a structural and morphometrical study in CCl4-treated rats

560

Hepatic mitochondrial transport of glutathione: Studies in isolated rat liver mitochondria and H4IIE rat hepatoma cells

561

Hepatic mono-oxygenase induction in benthic flatfish sampled near coastal pulp mills in British Columbia

562

Hepatic mucosa-associated lymphoid tissue (MALT) lymphoma associated with hepatitis C

563

Hepatic multi-nodular focal fatty metamorphosis in acquired porphyria cutanea tarda: Sonographic, CT, and mri features

564

Hepatic mycotic aneurysms

565

Hepatic myelopathy Case report with review of the literature

566

Hepatic myelopathy with spastic paraparesis

567

Hepatic necroinflammation and severe liver fibrosis in patients with chronic hepatitis B with undetectable HBV DNA and persistently normal alanine aminotransferase

568

Hepatic Necrosis: A Main Presentation of Systemic Lupus Erythematosus in a Previously Healthy Woman

569

Hepatic nodules in liver transplantation candidates: MR imaging and underlying hepatic disease

570

Hepatic Osteodystrophy: a relationship between osteoporotic bone and chronic liver disease

571

Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man

572

Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo

573

Hepatic overlap syndromes

574

Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage

575

Hepatic Oxidative Damages and Glucose Tolerance in Diabetic Rats Exposed to Repeated Oral Doses of Diazinon

576

Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients

577

Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis and chronic hepatitis

578

Hepatic parenchymal enhancement at Gd-EOB-DTPA-enhanced MR imaging: correlation with morphological grading of severity in cirrhosis chronic hepatitis

579

Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy

580

Hepatic portal venous gas

581

Hepatic portal venous gas: clinical significance of computed tomography findings

582

Hepatic production of VLDL1 but not VLDL2 is related to insulin resistance in normoglycaemic middle-aged subjects

583

Hepatic protection by perioperative metabolic support?

584

Hepatic protein synthesis rate of liver specimens as a predictor of viability in rat cold ischemia liver transplantation model

585

Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients

586

Hepatic pseudocapillarisation and atherosclerosis in ageing

587

Hepatic radiofrequency ablation using perfusion electrodes in a pig model: Effect of the Pringle manoeuvre

588

Hepatic reduction of insulin-like growth factor (IGF)-I and IGF binding protein-3 that results from fasting is not attenuated in genetically obese rats

589

Hepatic regeneration in insulin-like growth factor binding protein-1 transgenic mice

590

Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients, , , ,

591

Hepatic repopulation with stably transduced conditionally immortalized hepatocytes in the Gunn rat

592

Hepatic resection for hepatocellular carcinoma

593

Hepatic resection for hepatocellular carcinoma in Taiwan

594

Hepatic resection for large hepatocellular carcinoma

595

Hepatic resection for malignant melanoma

596

Hepatic resection for metastatic neuroendocrine carcinomas

597

Hepatic resection for recurrent metastatic ovarian cancer

598

Hepatic resection in breast cancer metastases: should it be considered standard treatment?

599

Hepatic resection in metastatic breast cancer: results and prognostic factors

600

Hepatic resection using stapling devices

601

Hepatic resection with vascular isolation and routine supraceliac aortic clamping

602

Hepatic retractor in an ex vivo model

603

Hepatic Rupture After Heimlich Maneuver

604

Hepatic Sarcodosis presenting as portal hypertension in a young boy

605

Hepatic sarcoidosis: MR appearances in patients with chronic liver disease

606

Hepatic Shock Differential Diagnosis and Risk Factors: A Review Article

607

Hepatic Sinusoidal Endothelial Cells Promote Hepatocyte Proliferation Early after Partial Hepatectomy in Rats

608

Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids

609

Hepatic Steatosis

610

Hepatic Steatosis Alleviated by a Novel Metformin and Quercetin Combination Activating Autophagy Through the cAMP/AMPK/SIRT1 Pathway

611

Hepatic Steatosis among Obese Children and Adolescents

612

Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening

613

Hepatic steatosis and insulin resistance: Does etiology make a difference?

614

Hepatic Steatosis and Related Factors in Obese Children Attending National Nutritional Institute

615

Hepatic steatosis and very low density lipoprotein secretion: the involvement of apolipoprotein E

616

Hepatic steatosis in chronic hepatitis B and C: Predictors, distribution and effect on fibrosis

617

Hepatic steatosis in HIV/HCV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study

618

Hepatic Steatosis in Iranian Patients with Chronic Hepatitis C

619

Hepatic steatosis is associated with a greater prevalence of coronary artery calcification in asymptomatic men

620

Hepatic steatosis: An experimental model for quantification

621

Hepatic stellate (ITO) cells: expanding roles for a liver-specific pericyte

622

Hepatic stellate cell activation in genetic haemochromatosis : Lobular distribution, effect of increasing hepatic iron and response to phlebotomy

623

Hepatic stellate cell activation occurs in nonalcoholic steatohepatitis

624

Hepatic stellate cell activation occurs in the absence of hepatitis in alcoholic liver disease and correlates with the severity of steatosis

625

Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers

626

Hepatic stellate cells (Ito-cells) but not collagen IV may partly be responsible for lower portal pressure after reversing secondary biliary cirrhosis in the rat

627

Hepatic stellate cells and the regulation of liver inflammation

628

Hepatic stellate cells are an important cellular site for β-carotene conversion to retinoid

629

Hepatic stellate cells become susceptible to fas-ligand induced apoptosis during transformation to myofibroblasts

630

Hepatic stellate cells do not derive from the neural crest

631

Hepatic stellate cells in human schistosomiasis mansoni: A comparative immunohistochemical study with liver cirrhosis

632

HEPATIC STELLATE CELLS IN THE CONTEXT OF LIVER FIBROSIS

633

Hepatic stem cells

634

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

635

Hepatic stress in hereditary tyrosinemia type 1 (HT1) activates the AKT survival pathway in the fah−/− knockout mice model

636

Hepatic tissue damage induced in Meriones ungliculatus due to infection with Babesia divergens-infected erythrocytes

637

Hepatic Tissue Engineering Using Scaffolds: State of the Art

638

Hepatic Toxocariasis in a Child: ACase Report from Shiraz, Southern Iran

639

Hepatic triacylglycerols and serum non-esterified fatty acids (NEFA) variations in indigenous water buffalo (Bubalus bubalis) in the province of Khuzestan, Iran

640

Hepatic tumor necrosis factors production and distant organ dysfunction in a murine model of obstructive jaundice

641

Hepatic tumours in childhood: An experience at the Children Hospital and Institute of Child Health, Lahore

642

Hepatic undifferentiated embryonal sarcoma: malignant evolution of mesenchymal hamartoma? Study of one case with immunohistochemical and flow cytometric emphasis

643

Hepatic vagotomy inhibits proliferation of hepatic stellate cells in rats with acute hepatitis

644

Hepatic vascular calcification: An early second trimester sonographic feature of idiopathic infantile arterial calcinosis

645

Hepatic vascular malformations in hereditary hemorrhagic telangiectasia: Doppler sonographic screening in a large family

646

Hepatic vein to the azygous vein anastomosis for pulmonary arteriovenous fistulae

647

Hepatic vein velocities in children with right ventricular hypertension

648

Hepatic vein waveform in liver cirrhosis: Correlation with Child’s class and size of varices

649

Hepatic veno-occlusive disease with immunodeficiency (VODI): First reported case in the U.S. and identification of a unique mutation in Sp110

650

Hepatic Venous Malformation After Modified Fontan Procedure With Partial Hepatic Vein Exclusion

651

Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy

652

Hepatic viral infections in Yemen between 2000-2005

653

Hepatic von Meyenburg complex simulating biliary cystadenocarcinoma

654

Hepatic, Renal and Cardiovascular Biomarker Variability in Type 2 Diabetes Mellitus Patients with Poor Glycemic Control

655

Hepaticocholecystoduodenostomy compared with Roux-en-y choledochojejunostomy for decompression of the biliary tract

656

Hepatiti C and Ocular urface Dieae Original Reearch Article

657

Hepatitis A 2004 Vaccination in Children: Methods and Findings of a Survey in Two States Original Research Article

658

Hepatitis A and B immunization in persons being evaluated for sexually transmitted diseases

659

Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus

660

Hepatitis A and E: not to be forgotten

661

Hepatitis A and vigorous physical activity

662

Hepatitis A booster vaccination: is there a need?

663

Hepatitis A Chronic Immunity in Iran: A Geographic Information System-Based Study

664

Hepatitis A Chronic Immunity: A Population-Based Seroprevalence Study in Fars Province, Southern Iran

665

Hepatitis A IgG seropositivity and coronary atherosclerosis assessed by angiography

666

HEPATITIS A IN LATIN AMERICA: A CHANGING EPIDEMIOLOGIC PATTERN

667

Hepatitis A in the Eastern Mediterranean Region: A Review on the Prevalence

668

Hepatitis A Infection Presented with Pancytopenia, a Case Series in Children

669

Hepatitis A Is a Health Hazard for Iranian Pilgrims Who Go to Holly Karbala: A Preliminary Report

670

Hepatitis A linked to clotting factors in USA

671

Hepatitis A Prevention Strategies, Haiti Case: Should Rescuers Be Immunized

672

Hepatitis A Seropositivity among First-Year Students of the Medical University in Isfahan, Iran

673

Hepatitis A seropositivity among newly admitted medical students of Isfahan, Kermanshah, and Hamedan: A seroprevalence study

674

Hepatitis a seroprevalence among young adults: Effects of ACIP immunization recommendations

675

Hepatitis A Seroprevalence and Associated Risk Factors: A Community-based Cross-sectional Study in Shahrekord, Iran

676

Hepatitis A Vaccination among Thai Medical Students: A Questionnaire Study

677

Hepatitis A vaccine failure

678

Hepatitis A vaccine for Israeli children

679

Hepatitis A vaccine for secondary hepatitis A infection

680

Hepatitis A vaccine for secondary hepatitis A infection

681

Hepatitis A vaccine for secondary hepatitis A infection

682

Hepatitis A vaccine for secondary hepatitis A infection

683

Hepatitis A vaccine for secondary hepatitis A infection

684

Hepatitis A vaccine in the last-minute traveler

685

Hepatitis A virus – a general overview

686

Hepatitis A Virus and Coronary Artery Diseases

687

Hepatitis A Virus and Hepatitis E Virus Seroprevalence Among Blood Donors in Tehran, Iran

688

Hepatitis A virus in environmental water samples from the Amazon Basin

689

Hepatitis A Virus Infection

690

Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV

691

Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers

692

Hepatitis A virus infection: Is it an important hazard to public health?

693

Hepatitis A Virus Seropositivity in Nurses and Paramedical Personnel at a University Hospital in North Iran

694

Hepatitis A virus vaccination in Iranian soldiers needs more attention

695

Hepatitis A Virus: Is Vaccination Necessary in Middle East?

696

Hepatitis A Virus: Seroepidemiological Study in Fars Province

697

Hepatitis A with Pleural Effusion, Ascites and Acalculous Cholecystitis

698

Hepatitis after intravenous buprenorphine misuse in heroin addicts

699

Hepatitis agent cloned and designated hepatitis G virus

700

Hepatitis and community: The current scenario and a roadmap for 2030

701

Hepatitis and death following vaccination with 17D-204 yellow fever vaccine

702

Hepatitis and HIV screening, education, and treatment for adults with serious mental illness

703

Hepatitis Awareness Bus: A Model for Finding Unknown Hepatitis B and C Infections

704

Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles

705

Hepatitis B and C among Patients Infected with Human Immunodeficiency Virus in Isfahan, Iran: Seroprevalence and Associated Factors

706

Hepatitis B and C among thalassemiac patients in Iran: A multicenter study

707

Hepatitis B and C among women with illegal social behavior in Isfahan, Iran: Seroprevalence and associated factors

708

Hepatitis B and C and the Role of Non-specialists on Disease Elimination

709

Hepatitis B and C in HIV-infected patients : Prevalence and prognostic value

710

Hepatitis B and C infection in first-time blood donors in Karachi – a possible subgroup for sentinel surveillance

711

Hepatitis B and C Infections Among Pediatric Patients with Sickle Cell Disease at a Tertiary Hospital in Nigeria

712

Hepatitis B and C Infections and Different Genotypes of HCV Among Sickle Cell Anemia Patients in Ahvaz, South-Western Iran

713

Hepatitis B and C Infections in Hamadan Province during 2004-2009

714

Hepatitis B and C knowledge among Saudi dental patients

715

Hepatitis B and C viral infection: prevalence, knowledge, attitude and practice among barbers and clients in Gharbia governorate, Egypt

716

Hepatitis B and C Viral Infection: Prevalence, Knowledge, Attitude, Practice, and Occupational Exposure among Healthcare Workers of Jimma University Medical Center, Southwest Ethiopia

717

Hepatitis B and C viral infections in chronic liver disease: a populationbased study in Qatar

718

Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges

719

Hepatitis B and C virus infection and the risk of atherosclerosis in a general population

720

Hepatitis B and C: An alarming situation in Southern part of Khyber Pakhtunkhwa, Pakistan

721

Hepatitis B and C: Prevention is better than cure

722

Hepatitis B and health-care workers

723

Hepatitis B and health-care workers

724

Hepatitis B and health-care workers

725

Hepatitis B and health-care workers

726

Hepatitis B and Hepatitis C in Patients with Inherited Disorders of Hemoglobin in Sistan and Baluchistan Province, Iran

727

Hepatitis B and Hepatitis C Seroprevalence in the Center of Sanliurfa Province From Southeastern Anatolia Region and Related Risk Factors

728

Hepatitis B and hepatitis C virus prevalence among dialysis patients in Bahrain and Saudi Arabia: A survey by serologic and molecular methods

729

Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences

730

Hepatitis B and HIV co-infection is still treated using lamivudine-only antiretroviral therapy combination in Uganda

731

Hepatitis B and its Relationship With Oxidative Stress

732

Hepatitis B associated liver failure following bone marrow transplantation

733

Hepatitis B Awareness and Knowledge in Asian Communities in British Columbia

734

Hepatitis B Birth Dose among Children in District 2 Hospital, Ho Chi Minh City, Vietnam: Prevalence and Associated Factors

735

Hepatitis B booster vaccination for healthcare workers

736

Hepatitis B Core Antibody ImmunoglobulinMin Blood Donors With a History of Hepatitis B Virus Infection

737

HEPATITIS B e ANTIGEN AND THE RISK OF HEPATOCELLULAR CARCINOMA

738

Hepatitis B e Antigen-Negative Chronic Hepatitis B

739

Hepatitis B envelope protein mutants

740

Hepatitis B epidemiology and cultural practices in Amerindian populations of Amazonia: The Tupí-Mondé and the Xavánte from Brazil

741

Hepatitis B genotypes and the response to interferon therapy

742

Hepatitis B Genotypes in Iran

743

Hepatitis B genotypes in patients with acute hepatitis B virus infection

744

Hepatitis B Immune Globulin in Liver Transplantation Prophylaxis: An Update

745

Hepatitis B immunisation in chronically transfused recipients

746

Hepatitis B immunisation in Singapore

747

Hepatitis B Immunization in Health Care Workers: Needs and Opportunities

748

Hepatitis B immunization in postpartum women

749

Hepatitis B in a high prevalence New Zealand population: A mathematical model applied to infection control policy

750

Hepatitis B in China

751

Hepatitis B infection among Asian American Pacific Islanders in the Rocky Mountain area

752

Hepatitis B Infection among Korean Americans in Colorado: Evidence of the Need for Serologic Testing and Vaccination

753

Hepatitis B infection among Nigerian children admitted to a children’s emergency room

754

Hepatitis B Infection among Patients Receiving Chronic Hemodialysis at the Royal Medical Services in Jordan

755

Hepatitis B Infection during Renal Replacement Therapy

756

Hepatitis B infection in Eastern Indian families: Need for screening of adult siblings and mothers of adult index cases

757

Hepatitis B infection in Eastern Mediterranean Region: challenges and the way forward

758

Hepatitis B Infection in Hemodialysis Patients in Tehran Province, Iran

759

Hepatitis B infection is highly endemic in Uganda: findings from a national serosurvey

760

Hepatitis B infection: Pathogenesis and management

761

Hepatitis B Infection: Prevalence and Response to Vaccination among Health Care Workers in Babol, Northern Iran

762

Hepatitis B is a Serious Health Problem in Some Parts of Iran; Sistan and Baluchestan Province

763

Hepatitis B Knowledge Among Healthy Volunteers in Duhok City, Kurdistan Region, Iraq

764

Hepatitis B Knowledge Among Iranian Adolescents: A National Survey

765

Hepatitis B or hepatitis C and human immunodeficiency virus infection

766

Hepatitis B pregenomic RNA splicing—The products, the regulatory mechanisms and its biological significance

767

Hepatitis B prevalence among workers in Turkey at low risk for hepatitis B exposure

768

Hepatitis B Prevention Education and Afghan Immigrant Students

769

Hepatitis B reactivation after lamivudine

770

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review

771

Hepatitis B Recurrence After Liver Transplantation: A Single Center Experiences and Review the Literature

772

Hepatitis B resistance in Iran

773

Hepatitis B Seroconversion Rate After Primary Immunization Series with Newly Introduced Pentavalent Vaccine: A Report of Local Study in Alborz Province, Iran, 2016

774

Hepatitis B seromarkers, hepatitis C antibody, and risk behaviors in married couples, a bordered province of western Thailand

775

Hepatitis B Seroprevalence and Risk Factors in Adult Population of Chaharmahal and Bakhtiari Province in 2013

776

Hepatitis B Seroprevalence and the Relationship Between Being Hepatitis B Vaccinated and Infected with Social Determinants of Health: Manisa, 2014

777

Hepatitis B Splice-Generated Protein Antibodies in Syrian Chronic Hepatitis B Patients: Incidence and Significance

778

Hepatitis B Stigma and Knowledge among Vietnamese in Ho Chi Minh City and Chicago

779

Hepatitis B surface antibody purification with hepatitis B surface antibody imprinted poly(hydroxyethyl methacrylate-N-methacryloyl-l-tyrosine methyl ester) particles

780

Hepatitis B surface antibody response of household contacts of hepatitis B virus carriers in Palestine

781

Hepatitis B Surface Antigen and Viral DNA Detection and Prevalence in Nigeria

782

Hepatitis B surface antigen carrier rate in unvaccinated and vaccinated children with thalassaemia major at Bahawal Victoria Hospital, Bahawalpur, Pakistan

783

HEPATITIS B SURFACE ANTIGEN DISAPPEARANCE AND HEPATITIS B SURFACE ANTIGEN SUBTYPE: A PROSPECTIVE, LONG-TERM, FOLLOW-UP STUDY OF JAPANESE RESIDENTS OF OKINAWA, JAPAN WITH CHRONIC HEPATITIS B VIRUS INFECTION

784

Hepatitis B Surface Antigen Prevalence among Pregnant Women in Rafsanjan City, Iran, 2003

785

Hepatitis B surface antigen prevalence in pregnant women: A cross‑sectional survey in Iran

786

Hepatitis B surface antigen, hepatitis C and HIV antibodies in a low-risk blood donor group, Nigeria

787

Hepatitis B Surface Antigen, Hepatitis C Virus Antibody, Body Mass Index, and Alcohol Drinking among Workers with Elevated Serum Alanine Aminotransferase

788

Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria

789

Hepatitis B surface antigen-negative, but HBV DNA-positive patients in Bangladesh

790

Hepatitis B testing among Vietnamese American men

791

Hepatitis B transmission from contaminated cryopreservation tank

792

Hepatitis B vaccination after liver transplantation as a strategy to discontinue prophylaxis with hepatitis B immune globulin

793

Hepatitis B vaccination among primary health care workers in Northwest Pakistan

794

HEPATITIS B VACCINATION AND INFANTILE IDIOPATHIC THROMBOCYTOPENIC PURPURA

795

Hepatitis B vaccination coverage among Iranian children aged 15–26 months in 2006

796

Hepatitis B Vaccination Coverage Among Iranian Medical Students and Nursing Staff

797

Hepatitis B Vaccination Coverage and Its Associated Factors in Nurses of Imam Reza (AS) Hospital in Kermanshah

798

Hepatitis B Vaccination Coverage and Sharp Injuries Among Healthcare Workers in Hamadan, Iran

799

Hepatitis B vaccination coverage in medical students at a medical college of Mirpurkhas

800

Hepatitis B Vaccination Coverage, HBS-Ab Level and its Related Factors among Dentistry and Medical Students

801

Hepatitis B Vaccination Efficacy in Iranian Healthcare Workers: A Meta-Analysis Study

802

Hepatitis B vaccination follow-up

803

Hepatitis B Vaccination in Bangladesh: a Suggestion Based on Current Evidence

804

Hepatitis B Vaccination in Chronic Kidney Disease: Review of Evidence in Non-Dialyzed Patients

805

Hepatitis B vaccination in correctional health care workers

806

Hepatitis B vaccination in correctional health care workers

807

Hepatitis B vaccination of babies in Melanesia

808

Hepatitis B vaccination of health care workers in Saudi Arabia

809

Hepatitis B vaccination program at a New York City hospital: Seroprevalence, seroconversion, and declination, ,

810

Hepatitis B Vaccination Reliability in Celiac Disease

811

Hepatitis B Vaccination Status in Dental Practitioners: Local Horrifying Report, National Considerable Issue, and Global Health Impact

812

Hepatitis B vaccination strategy for newborn babies

813

Hepatitis B Vaccination: Needs a Revision

814

Hepatitis B vaccination: to boost or not to boost?

815

Hepatitis B Vaccine Acceptability among Nurses: A Theory Based Conceptualization

816

Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy

817

Hepatitis B vaccine booster dose: Low-dose recombinant hepatitis B vaccines as a booster dose,

818

Hepatitis B vaccine boosting among young healthy adults

819

Hepatitis B vaccine boosting: the debate continues

820

Hepatitis B Vaccine Coverage and the Immune Response in Children under ten years old in Sana’a, Yemen

821

Hepatitis B vaccine in patients on haemodialysis

822

Hepatitis B vaccine, hepatitis C virus infection, and haemodialysis

823

Hepatitis B Vaccine: Immunity, Efficacy and Types.

824

Hepatitis B Viral DNA Among HBs Antigen Negative Healthy Blood Donors

825

Hepatitis B viral genotypes and lamivudine resistance

826

Hepatitis B Viral Markers in Surface Antigen Negative Blood Donors: The Need to Look Beyond Antibody Negativity

827

Hepatitis B viral resistance: mechanisms and diagnosis

828

Hepatitis B viral X protein interacts with tumor suppressor adenomatous polyposis coli to activate Wnt/β-catenin signaling

829

Hepatitis B Virus (HBV) and Occult Hepatitis B Virus (OBI) in Hemodialysis Patients: An Epidemiological Observational Study in Kerman, Iran (2022-2023)

830

Hepatitis B virus (HBV) DNA assays (methods and practical use) and viral kinetics

831

Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria

832

Hepatitis B virus (HBV) vaccine-induced escape mutants of HBV S gene among children from Qidong area, China

833

Hepatitis B Virus / Human Immunodeficiency Virus Co-Infection and Its Hepatocarcinogenic Potential in Sub-Saharan Black Africans

834

Hepatitis B virus among maintainence haemodialysis patients: A report from Karachi, Pakistan

835

Hepatitis B virus among schoolchildren in an endemic area in Egypt over a decade: Impact of hepatitis B vaccine

836

Hepatitis B virus and celiac disease

837

Hepatitis B Virus and Cytomegalovirus Infections Disrupt Sperm Parameters in Males through Decreasing Mitochondrial Membrane Potential: A Case-control Study

838

Hepatitis B virus and hepatocellular carcinoma

839

Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda

840

Hepatitis B virus and host factors

841

Hepatitis B Virus and Malaria Co-infection Causing Significant Changes in Hematological and Liver Function Indices in a Cohort of Subjects in Ilorin, Nigeria

842

Hepatitis B Virus Antibody Levels in High-Risk Health Care Workers

843

Hepatitis B virus clearance by transplantation of bone marrow from hepatitis B immunised donor

844

Hepatitis B Virus Complications of Pregnancy After Kidney Transplantation

845

Hepatitis B Virus Core Promoter Mutations in Patients With Chronic Hepatitis B and Hepatocellular Carcinoma in Bucharest, Romania

846

Hepatitis B virus DNA in sera and liver tissue of HBsAg negative patients with chronic hepatitis C

847

Hepatitis B Virus DNA is Absent in Lebanese Blood Donors Who Are Positive for Both Anti-Hbc and Anti-Hbs Antibodies

848

Hepatitis B virus DNA level Among the Seropositive Afghan Immigrants, Southern Iran

849

Hepatitis B virus DNA level as predictor of response to therapy with interferon-alpha-2b (PDferon) in chronic hepatitis B infection

850

Hepatitis B virus E antigen but not HBV core is presented to specific CD4+ T cells via the endogenous antigen processing pathway

851

Hepatitis B virus enhances interleukin-27 expression both in vivo and in vitro

852

Hepatitis B virus enhances transduction of human hepatocytes by SV40-based vectors

853

Hepatitis B virus enhances tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) cytotoxicity by increasing TRAIL-R1/death receptor 4 expression

854

Hepatitis B virus genetic diversity in Latin America

855

Hepatitis B virus genetic variability and evolution

856

Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma

857

Hepatitis B Virus Genotype B and High Expression of Interferon Alpha Receptor β Subunit are Associated With Better Response to Pegylated Interferon Alpha 2a in Chinese Patients With Chronic Hepatitis B Infection

858

Hepatitis B Virus Genotype G Infection in a Turkish Patient Undergoing Hemodialysis Therapy

859

Hepatitis B virus genotypes and extrahepatic manifestations

860

Hepatitis B Virus Genotypes Distribution with HBsAg Positive in the North of Iran (Mazandaran) During 2011-2014

861

Hepatitis B Virus Genotypes in Eastern Azerbaijan, Northwest Iran

862

Hepatitis B virus genotypes, core gene variability and ethnicity in the Pacific region

863

Hepatitis B Virus Genotypes, Epidemiological Characteristics, and Clinical Presentation of HBV Chronic Infection in Immigrant Populations Living in Southern Italy

864

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

865

Hepatitis B Virus Genotyping Among Chronic Hepatitis B Individuals With Resistance to Lamivudine in Shahrekord, Iran

866

Hepatitis B virus Genotyping Among Patients With Cirrhosis

867

Hepatitis B Virus Immunity Status and Booster Dose Efficacy in Health Sciences Students: An Interventional Study

868

Hepatitis B virus in cervicovaginal lavage samples of pregnant women in Gorgan city, north of Iran

869

Hepatitis B virus induced hepatocellular carcinoma

870

Hepatitis B Virus Infection among Health Colleges’ Students in Aseer Region, Southwestern Saudi Arabia

871

Hepatitis B virus infection among staff in three hospitals in Khartoum, Sudan, 2006–07

872

Hepatitis B Virus Infection and Exposure Among Foreign-Born Asian Americans in the U.S.

873

Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran

874

Hepatitis B Virus Infection and Oral Lichen Planus: A Report from Northeast of Iran

875

Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma

876

Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention

877

Hepatitis B Virus Infection Flare Induced Acute-on-chronic Liver Failure After COVID-19 Vaccination: A Case Report

878

HEPATITIS B VIRUS INFECTION IN AN ANTI-HBC NEGATIVE PATIENT: A CASE REPORT

879

Hepatitis B virus infection in Iran

880

Hepatitis B Virus Infection in Iran: A Systematic Review

881

Hepatitis B Virus Infection in Iran: Current Knowledge, Future Plans

882

Hepatitis B Virus Infection in Iranian Hemodialysis Patients A Systematic Review and Meta-Analysis

883

Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers

884

Hepatitis B Virus Infection in Patients with Blood Disorders: A Concise Review in Pediatric S

885

Hepatitis B Virus Infection in the General Population of Iran: An Updated Systematic Review and Meta-Analysis

886

Hepatitis B Virus Infection in Vaccinated Children and Adolescents with HBsAg-positive Parents: Is Routine Vaccination Sufficient?

887

Hepatitis B Virus Infection Serology and the Associated Risk Factors Among Patients With HIV in Shiraz, Iran

888

Hepatitis B virus infection without immunological markers after open-heart surgery

889

Hepatitis B virus infection: Current status

890

Hepatitis B Virus Infection; A Vanishing Disease in Iranian Children

891

Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis

892

Hepatitis B virus large surface protein: function and fame

893

Hepatitis B virus mutants and efficacy of vaccination

894

Hepatitis B virus mutants and efficacy of vaccination

895

Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation

896

Hepatitis B virus precore mutants in serum and liver of Southern African Blacks with hepatocellular carcinoma

897

Hepatitis B Virus PreS Variant and Hepatocellular Carcinoma

898

Hepatitis B Virus preS2 Domain Promotes Angiogenesis in Hepatocellular Carcinoma via Transcriptional Activation of VEGFA Promoter

899

Hepatitis B virus quasispecies susceptibility to entecavir confirms the relationship between genotypic resistance and patient virologic response

900

Hepatitis B Virus Reactivation Potential Risk Factors in Hepatocellular Carcinoma via Transcatheter Arterial Chemoembolization: A Retrospective Research

901

Hepatitis B virus replication and viral antigen synthesis in hepatocyte lines derived from normal human liver

902

Hepatitis B virus resistance to antivirals: clinical implications and management

903

Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy

904

Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis

905

Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese

906

Hepatitis B Virus Should not be Forget in Health Care Worker

907

Hepatitis B virus subtypes and lamivudine resistance

908

Hepatitis B Virus Surface Antigen (HBsAg) Mutations Are Rare but Clustered in Immune Epitopes in Chronic Carriers from Sistan-Balouchestan Province, Iran

909

Hepatitis B Virus Surface Antigen Variants Clustered Within Immune Epitopes in Chronic Hepatitis B Carriers from Hormozgan Province, South of Iran

910

Hepatitis B virus transmission and hepatocarcinogenesis: a 9 year retrospective cohort of 13 676 relatives with hepatocellular carcinoma

911

Hepatitis B Virus Vaccination in Hemodialysis Patients: A Necessity for Individualizing of Immunization?

912

Hepatitis B Virus Vaccine immune response in Egyptian children 15-17 years after primary immunization; should we provide a booster dose?

913

Hepatitis B virus viral dynamics: effects of drug dose and baseline alanine aminotransferase

914

Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish

915

Hepatitis B virus X gene is implicated in liver carcinogenesis

916

Hepatitis B virus X mediates podocyte pyroptosis by regulating the ROS/NLRP3 signaling pathway in hepatitis B virus-associated glomerulonephritis

917

Hepatitis B virus X protein (HBx) activates ATF6 and IRE1-XBP1 pathways of unfolded protein response

918

Hepatitis B virus X protein induced expression of interleukin 18 (IL-18): a potential mechanism for liver injury caused by hepatitis B virus (HBV) infection

919

Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression

920

Hepatitis B virus X protein interacts with NF-KB inhibitors

921

Hepatitis B virus X protein overcomes stress-induced premature senescence by repressing p16INK4a expression via DNA methylation

922

Hepatitis B virus X protein promotes cell migration by inducing matrix metalloproteinase-3

923

Hepatitis B virus X protein stimulates the Hedgehog–Gli activation through protein stabilization and nuclear localization of Gli1 in liver cancer cells

924

Hepatitis B Virus X Protein Up-Regulates AKR1C1 Expression Through Nuclear Factor-Y in Human Hepatocarcinoma Cells

925

Hepatitis B virus YMDD-motif mutations with emergence of lamivudine-resistant mutants: a threat to recovery

926

Hepatitis B Virus, Hepatitis C Virus Markers and Serum Alanine Amino-Transferase (ALT) Levels, in a Young Adult Population of Sylhet District

927

Hepatitis B Virus-associated Glomerulonephritis

928

Hepatitis B Virus-associated Nephropathy An International Data Analysis

929

Hepatitis B viruses and cancerogenesis

930

Hepatitis B viruses: Reverse transcription a different way

931

Hepatitis B virus-induced hepatocellular carcinoma

932

Hepatitis B virus-infected cells can be eliminated by the cytotoxic T cell-mediated immune reaction. Fas ligand, recently detected on the surface of cytotoxic T cell, is thought to induce cells to apoptosis by adhering to Fas antigen. Aims/Methods: To eva

933

Hepatitis B virus-related vasculitis manifesting as severe peripheral neuropathy following influenza vaccination

934

Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran

935

Hepatitis B, Hepatitis C and HIV seroprevalence in critically ill emergency medicine department patients in a tertiary inner city hospital in Istanbul, Turkey

936

Hepatitis B, Hepatitis C and Human Immunodeficiency Virus Seropositivity Among Children in Kabul, Afghanistan: A Cross-Sectional Study

937

Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon

938

Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015

939

Hepatitis B, Hepatitis C, and Human Immunodeficiency Virus Infection in Multi-Transfused Thalassemic Patients, Kermanshah, Iran, 2015

940

Hepatitis B, hepatitis C, HIV, and VDRL seroprevalence of blood donors in Mersin, Turkey*

941

Hepatitis B: Epidemiology and prevalence in Iran, during 2002-2014

942

Hepatitis B: Knowledge, Vaccine Situation and Seroconversion of Dentistry Students of a Public University

943

Hepatitis B: Reflections on the current approach to antiviral therapy

944

Hepatitis BMarkers in Isfahan, Central Iran: APopulation-Based Study

945

Hepatitis B-Related Concerns and Anxieties Among People With Chronic Hepatitis B in Australia

946

Hepatitis C (HCV) Viremic Rate and its Correlation to Demographic Factors among HCV Confirmed Iranian Blood Donors

947

Hepatitis C among Hemodialysis Patients: A Review on Epidemiologic, Diagnostic, and Therapeutic Features

948

Hepatitis C among Hemodialysis Patients: Impact of Strict Adherence to Universal Precautions

949

Hepatitis C among Intravenous Drug Users in Isfahan, Iran: A Study of Seroprevalence and Risk Factors

950

HEPATITIS C AMONG YOUNG MALE OFFENDERS ADMITTED TO THE CENTRAL JAIL, LAHORE

951

Hepatitis C and alcohol

952

Hepatitis C and B-cell lymphoma: the hemato-hepatologist linkage

953

Hepatitis C and B-cell non-Hodgkin’s lymphoma: a geographicallyvariable association?

954

Hepatitis C and blood transfusion among children attending the Sickle Cell Clinic at Mulago Hospital, Uganda

955

Hepatitis C and Depression

956

Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern Iran

957

Hepatitis C and hepatitis B seroprevalence and associated risk factors in hemodialysis patients in Guilan province, north of Iran

958

Hepatitis C and Hepatitis B Virus Infection: Epidemiology and Risk Factors in a Large Cohort of Pregnant Women in Lorestan, West of Iran

959

Hepatitis C and HIV infection: biological, clinical, and therapeutic implications

960

Hepatitis C and hospital outcomes in patients admitted with alcohol-related problems

961

Hepatitis C and liver transplantation

962

Hepatitis C and pulmonary fibrosis

963

Hepatitis C and renal failure

964

Hepatitis C and Steatosis

965

Hepatitis C and Teens

966

Hepatitis C and Teens

967

Hepatitis C and the correctional population

968

Hepatitis C and the heart: to beat or not to beat

969

Hepatitis C and thyroid autoimmunity: is there a link?

970

Hepatitis C and Why the Treatment is Needed Now? The Summary Report From the Cross-Border Symposium of the 5th Tehran Hepatitis Congress May 2013

971

Hepatitis C at work place: A survey of Occupational Health and Safety Knowledge and Practice in Beauty Therapy Industry

972

Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era

973

Hepatitis C detection

974

Hepatitis C detection

975

Hepatitis C genotype and associated risks factors of patients at University Kebangsaan Malaysia Medical Centre

976

Hepatitis C Genotypes Distribution in Intravenous Drug Users in Tehran

977

Hepatitis C Genotypes in Hemophilia Patients in Iran

978

Hepatitis C Genotypes in Hemophilia Patients in Iran

979

Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma

980

HEPATITIS C IN A COMMUNITY IN UPPER EGYPT: I. CROSS-SECTIONAL SURVEY

981

Hepatitis C in Australia: Impact of a Mass Media Campaign Original Research Article

982

Hepatitis C in haemophilia patients in the Netherlands

983

Hepatitis C in Hemodialysis Centers of Golestan Province, Northeast of Iran (2005)

984

Hepatitis C in hemodialysis patients needs more attention for control and review the risk factors

985

Hepatitis C in Iran. How Extensive of a Problem Is It?

986

Hepatitis C in Pakistan: A Review of Available Data

987

HEPATITIS C IN PERU: RISK FACTORS FOR INFECTION, POTENTIAL IATROGENIC TRANSMISSION, AND GENOTYPE DISTRIBUTION

988

Hepatitis C in State Correctional Facilities

989

Hepatitis C in the Eastern Mediterranean Region

990

Hepatitis C in the patient with human immunodeficiency virus infection

991

Hepatitis C Infection Among HIV-Positive Injection Drug Users and Non-Injection-Drug Users in Tajikistan

992

Hepatitis C infection and autoimmune hemolytic anemia in a patient with colon B-cell non-hodgkin lymphoma: a case report

993

Hepatitis C infection and polymyositis

994

Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis

995

Hepatitis C infection from anti-D immunoglobulin

996

Hepatitis C Infection in Egyptian Psoriatic Patients: Prevalence and Correlation with Severity of Disease

997

Hepatitis C infection in Iran; A review article

998

Hepatitis C Infection in the General Population of Iran: A Systematic Review

999

Hepatitis C infection increases the risk of new-onset diabetes after transplantation in liver allograft recipients

1000

Hepatitis C infection is characterized by a high incidence of liver cirrhosis, frequently requiring liver transplantation. After orthotopic liver transplantation, recurrence of hepatitis C virus infection is common, but often difficult to differentiate fr

بازگشت